BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 236
- Registration Number
- NCT06415019
- Locations
- πΊπΈ
TKL Research, Inc., Fair Lawn, New Jersey, United States
A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-09-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 40
- Registration Number
- NCT06412926
- Locations
- π©πͺ
NUVISAN GmbH Neu-Ulm, Neu-Ulm, Bayern, Germany
A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function
- First Posted Date
- 2024-05-07
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT06402721
- Locations
- πΊπΈ
Orlando Clinical Research Center (OCRC), Orlando, Florida, United States
A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 21
- Registration Number
- NCT06378658
- Locations
- πΊπΈ
Parexel Baltimore - Early Phase Clinical Unit, Baltimore, Maryland, United States
An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in Japan
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Bayer
- Target Recruit Count
- 5740
- Registration Number
- NCT06373159
- Locations
- π―π΅
Bayer, Tokyo, Japan
An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1400
- Registration Number
- NCT06363110
- Locations
- πΊπΈ
Bayer, Whippany, New Jersey, United States
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-04-11
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 15
- Registration Number
- NCT06360211
- Locations
- πΊπΈ
Parexel Baltimore - Early Phase Clinical Unit, Baltimore, Maryland, United States
A Study to Learn About How Itraconazole and Carbamazepine Affect the Level of BAY2927088 in the Blood When These Drugs Are Taken Together by Healthy Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 30
- Registration Number
- NCT06348888
- Locations
- πΊπΈ
Parexel Baltimore - Early Phase Clinical Unit, Baltimore, Maryland, United States
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-03
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 17
- Registration Number
- NCT06345001
- Locations
- πΊπΈ
HonorHealth Research Institute, Scottsdale, Arizona, United States
πΊπΈCity of Hope National Medical Center, Duarte, California, United States
πΊπΈUniversity of Southern California (USC) - Norris Comprehensive Cancer Center, Los Angeles, California, United States
An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 600
- Registration Number
- NCT06334120
- Locations
- π°π·
Multiple locations, Multiple Locations, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath